Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are anticipating strong growth driven by the continued https://adreaybmd358969.bloggosite.com/44226651/eli-lilly-stock-a-deep-dive-into-q3-earnings